Rocket Pharmaceuticals (RCKT) PT Lowered to $69 at JPMorgan, Following Earnings

February 25, 2021 12:57 PM EST
Get Alerts RCKT Hot Sheet
Price: $43.39 -0.94%

Rating Summary:
    13 Buy, 1 Hold, 1 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 17 | Down: 13 | New: 41
Trade Now! 
Join SI Premium – FREE

Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.

JPMorgan analyst Eric Joseph lowered the price target on Rocket Pharmaceuticals (NASDAQ: RCKT) to $69.00 (from $71.00) while maintaining a Overweight rating.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Analyst PT Change

Related Entities

JPMorgan, Earnings